BTBP(SH:600161) Shang Hai Zheng Quan Bao·2025-09-29 21:27Group 1 - The company announced the resignation of its Chief Compliance Officer and General Counsel, Ms. Ci Xiang, who submitted her resignation report to the board [1] - Ms. Ci Xiang will continue to serve on the board of the company's subsidiary, China National Pharmaceutical Group Xi'an Biological Pharmaceutical Co., Ltd. (Tian Tan Xi'an), until a new director is elected [1] - The company will expedite the appointment of a new director for Tian Tan Xi'an [1] Group 2 - As of the announcement date, Ms. Ci Xiang directly holds 24,000 shares of the company, accounting for 0.0012% of the total shareholding [2] - Ms. Ci Xiang will continue to adhere to her commitment not to reduce her shareholding within the statutory period [2] - The resignation will not affect the normal operations of the company, and the board expressed gratitude for Ms. Ci Xiang's contributions over the years [2]